Cliff Asness’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Cliff Asness’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-552,753	Closed	-$3.69M	–	2476
2023 Q3	$3.69M	Buy	552,753 +97	+0%	+$806	0.01%	1056
2023 Q2	$5.01M	Buy	552,656 +542,148	+5,159%	+$4.78M	0.01%	902
2023 Q1	$76.4K	Sell	10,508 -107	-1%	-$794	﹤0.01%	2129
2022 Q4	$77.4K	Buy	+10,615	New	+$78.8K	﹤0.01%	2153

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Cliff Asness's PNT Position: Q4 2023 in Review

Cliff Asness sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 552,753 shares — an estimated $3.69M sold.

Cliff Asness first reported a position in PNT in Q4 2022 and held it in 4 quarters. The position peaked at $5.01M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Cliff Asness reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Cliff Asness sold 552,753 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $3.69M.
Cliff Asness first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2022 and held it in 4 quarters.
Cliff Asness's POINT Biopharma Global Inc. Common Stock position peaked at $5.01M in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.